UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Sales, net	$ 37,860	$ 25,121	$ 25,916
Cost of goods sold	15,460	11,911	12,127
Gross profit	22,400	13,209	13,789
Sales and marketing	(2,815)	(1,537)	(1,584)
Research and development	(518)	(397)	(361)
General and administrative	(7,225)	(2,354)	(2,412)
Operating income	11,842	8,922	9,432
Dividend and interest income	16	48	206
Capital gains and (losses) on investments	1	(9)	6
Royalty income	71	0	0
Interest expense	(859)	(25)	(51)
Other, net	10	104	(14)
Income before provision for income taxes	11,080	9,041	9,580
Provision for income taxes	3,666	3,026	3,322
Net income	7,414	6,014	6,258
Earnings per common shares (basic)	$ 2.04	$ 1.66	$ 1.73
Earnings per common share (diluted)	$ 2.03	$ 1.65	$ 1.72
Foreign currency translation net of taxes of $(635), $(127) and $44	(993)	(199)	68
Unrealized gain (loss) on investments net of taxes of $(2), $29 and $10	(3)	45	15
Total comprehensive income	$ 6,418	$ 5,860	$ 6,341